CDK1 and familial pancreatic carcinoma: Inhibition of the kinase activity of CDK1 can prevents the expression of relevant immune checkpoints, alters the tumor microenvironment, and can significantly improve the overall survival rate in a mouse pancreatic cancer tumor model [86].